tbuckley/cabot-search huggingface dataset:
A Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Dual CK1ε/PI3Kδ Inhibitor HZ-H08905 in Adult Patients with Relapsed and/or Refractory Hematologic Malignancies
Authors: Juying Wei, Wenjuan Yu, Zhengming Jin, Keshu Zhou, Haiyan Yang, Fei Li, Lanfang Li, Miao Hu, Xinglu Zhou, Jie Jin
Journal: Blood (2023)
A Phase Ib Study to Evaluate the Safety and Efficacy of Nivolumab in Combination with R-CHOP in High-Risk DLBCL
Authors: Oluwatobi Odetola, Shuo Ma, Jane N. Winter, Barbara Pro, Ishan Roy, Ping Xie, Bin Zhang, George Koulogeorgas, Xinlei Mi, Robert Bayer, Robert Eisner, Valerie Nelson, Habib Shaikh, Dean Tsarwhas, Faisal Saghir, Parameswaran Venugopal, Leo I. Gordon, Reem Karmali
Journal: Blood (2023)
Lower Prognostic Performance of the International Metabolic Prognostic Index Compared to the Conventional IPI and NCCN-IPI in a Real-World Cohort of Diffuse Large B-Cell Lymphoma
Authors: Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Kosei Matsue
Journal: Blood (2023)
Analysis of Post-Transplant Clinical Outcomes and Prognostic Factors in FLT3-ITD Mutated Acute Myeloid Leukemia Patients Under ELN 2022 Risk Stratification
Authors: Chen Liang, Aiming Pang, Yi He, Donglin Yang, Rongli Zhang, Qiaoling MA, Mingzhe Han, Sizhou Feng, Erlie Jiang
Journal: Blood (2023)
Hematological Parameters: Comparative Evaluation of Performance between Dxh 500 and XN-10 Equipments
Authors: Viviane Regina Regina Hernandez Hernandez Nunes, Rosana Moreira Cosentino Penteado, Andrea Tiemi Kondo, Afonso Cardoso, Nelson Hamerschlak, Alfredo Mendrone, Andrea Rocco Villarinho, Denise Cristine de Oliveira, Joao Carlos de Campos Guerra
Journal: Blood (2023)
The CD38/CD3xCD28 Trispecific Antibody (SAR442257) Potentially Represents a Novel Therapeutic Strategy for Peripheral T-Cell Lymphomas
Authors: Aurélie Dupuy, Laura Pelletier, Jerome Giustiniani, Peter Kim, Kamlesh Bisht, Hongfang Wang, Helgi J. Van de Velde, Corinne Haioun, Philippe Gaulard, Nicolas Ortonne
Journal: Blood (2023)
Low Disease Relapse and High Survival in Non-Myeloablative Two-Step Haploidentical Transplant, Results of a Prospective Trial
Authors: Xia Bi, Dolores A. Grosso, John L. Wagner, Joanne Filicko-O'Hara, William O'Hara, Neal Flomenberg, Usama Gergis
Journal: Blood (2023)
Incidence and outcomes of subsequent malignancy after allogeneic hematopoietic stem cell transplantation in adult patients with severe aplastic anemia
Authors: Daehun Kwag, Jong-Wook Lee, Gi-June Min, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho
Journal: Blood (2023)
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) and Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (DKRd) As Induction Therapy in Newly Diagnosed Multiple Myeloma
Authors: Carlyn Tan, Kylee H Maclachlan, David Nemirovsky, Andriy Derkach, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi A Shah, Sridevi Rajeeve, Dhwani Patel, Tala Shekarkhand, Colin Rueda, Oscar Boutros Lahoud, Gunjan L. Shah, Michael Scordo, David Chung, Heather Landau, Sergio A. Giralt, Alexander Lesokhin, Saad Z Usmani, Neha Korde
Journal: Blood (2023)
Machine Learning-Based Decision Tree for Identifying and Grading Severity of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Based on Neurological Adverse Events in Patients Treated with CD19 CAR-T
Authors: Alexandru Socolov, Penelope Lafeuille, Sheila Diamond, Eric Yang, Francesco Maura, Jacob Aptekar, Esther Nie
Journal: Blood (2023)
The Outcome of Diffuse Large B-Cell Lymphoma Patients with Testicular Involvement - Real World Data
Authors: Heidi Mocikova, Andrea Janikova, Alice Sykorova, Vit Prochazka, Jan Pirnos, Juraj Duras, Katerina Kopeckova, Katerina Steinerova, Robert Pytlik, Petra Blahovcova, David Salek, Tomas Kozak, Veronika Bachanova, David Belada
Journal: Blood (2023)
Histologic and Molecular Correlates in Patients with AL Amyloidosis in Hematologic Remission but with Persistent Renal Disease
Authors: Cindy Varga, Felix Eichinger, Abhijit Naik, Viji Nair, Samih Nasr, Agnes Fogo, Denis Toskic, Matthias Kretzler, Raymond Comenzo
Journal: Blood (2023)
Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study)
Authors: Ji Hyun Lee, Chang-Ki Min, Jae-Cheol Jo, Yoo Jin Lee, Jin Seok Kim, Hyun-Seok Uhm, Jong Heon Jung, Joon Ho Moon, Hee Jeong Cho, Myung-won Lee, Sung-Soo Yoon, Ja Min Byun, Jae Hoon Lee, Je-Jung Lee, Sung-Hoon Jung, Ho-Jin Shin, Do Young Kim, Jun Ho Yi, Seung-Shin Lee, Young Rok Do, Dok Hyun Yoon, Hyungwoo Cho, Won-Sik Lee, Ho Sup Lee, Jieun Uhm, Hyo Jung Kim, Hee Ryeong Jang, Sung-Hyun Kim, Kihyun Kim
Journal: Blood (2023)
Quantitative Analysis of Bone Marrow Features Highlights Heterogeneity in Myelofibrosis Patients Treated with Zinpentraxin Alfa in a Phase II Clinical Study
Authors: Hosuk Ryou, Korsuk Sirinukunwattana, Ruby Wood, Alan Aberdeen, Jens Rittscher, Olga Weinberg, Robert Hasserjian, Olga Pozdnyakova, Frank Peale, Brian Higgins, Pontus Lundberg, Kerstin Trunzer, Claire N Harrison, Daniel Royston
Journal: Blood (2023)
Risk Stratification Models Overestimate Progression Risk in Contemporary Patients with Smoldering Multiple Myeloma (SMM)
Authors: George Mellgard, Molly Gilligan, Edward R Scheffer Cliff, Divaya Bhutani, Ghulam Rehman Mohyuddin, Andrew Eisenberger, Suzanne Lentzsch, Rajshekhar Chakraborty
Journal: Blood (2023)
A Phase 1b Trial of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Myelofibrosis and Anemia
Authors: Naseema Gangat, James M. Foran, Anna B. Halpern, Raajit K. Rampal, Natasha Novikov, Akshay Buch, Olivia Pelletier, William Savage, Ayalew Tefferi
Journal: Blood (2023)
CM313, a Novel Anti-CD38 Antibody, As a Potential Treatment for Primary Immune Thrombocytopenia: A Phase II Trial
Authors: Yunfei Chen, Xu Yanmei, Xuan Cao, Feng Xue, Ting Sun, Wei Liu, Mankai Ju, Rongfeng Fu, Xiaofan Liu, Xinyue Dai, Huiyuan Li, Renchi Yang, Lei Zhang
Journal: Blood (2023)
Real World Experience of FLT3-Inhibitor Post-Transplant Maintenance with Sorafenib Demonstrating Superior Overall- and Relapse Free Survival Following Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD Mutated Acute Myeloid Leukemia
Authors: Yomna Eissa, Eshrak Al-Shaibani, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Jose-Mario Capo-chichi, Arjun D. Law, Fotios Michelis, Auro Viswabandya, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Dennis D. H. Kim
Journal: Blood (2023)
Treatment Outcomes and Prognostic Factors with Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone Versus Rvd Plus Autologous Stem Cell Transplantation (ASCT) in African American (AA) Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the Determination Phase 3 Trial
Authors: Christiane A. Houde, Abdullah Khan, Susanna J. Jacobus, Hani Hassoun, Larry D. Anderson, Lauren E. Merz, Rebecca L. Zon, Yvonne Efebera, Tondre Buck, Racquel D. Innis-Shelton, Monique A Hartley-Brown, Sagar Lonial, Erica L. Campagnaro, Peter M. Voorhees, Robert Z. Orlowski, Edward Libby, David Duane Hurd, Caitlin L. Costello, Noopur S. Raje, Eva Medvedova, Philip L. McCarthy, Carter P. Milner, Cristina Gasparetto, Mounzer E Agha, Krisstina Gowin, Rammurti T. Kamble, Sundar Jagannath, Nitya Nathwani, Melissa Alsina, Sergio A. Giralt, Jacob P. Laubach, Omar Nadeem, Irene M. Ghobrial, Clifton C. Mo, Mehmet K. Samur, Kenneth C. Anderson, Nikhil C Munshi, Paul G. Richardson
Journal: Blood (2023)
Clonal Hematopoiesis Is Associated with Severe Cytokine Release Syndrome in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Authors: Scott R. Goldsmith, Geoffrey P. Shouse, F. Lennie Wong, Alysia Bosworth, Aleksi Iujuridze, Sitong Chen, June-Wha Rhee, Matthew G. Mei, Murali Janakiram, Myo Htut, Stephen J. Forman, Raju Pillai, L. Elizabeth Budde, Saro Armenian
Journal: Blood (2023)
Computational Approach Based on Independent Drug Action Identifies Clinically Relevant Combinations for Acute Myeloid Leukemia
Authors: Xiao Xian Lin, Vedant Sandhu, Christopher A. Eide, Stephen E. Kurtz, Disha Malani, Tom Erkers, Olli Kallioniemi, Jeffrey W Tyner, Shruti Bhatt
Journal: Blood (2023)
<i>In Vitro</i> Analysis of Bone Remodeling Alterations in Hemophilia: Influence of Coagulation Factors on Bone Cells
Authors: Stefano Lancellotti, Giulia Battafarano, Monica Sacco, Maira Tardugno, Leonardo Di Gennaro, Matteo Luciani, Raimondo De Cristofaro, Andrea Del Fattore
Journal: Blood (2023)
<i>Feasibility and Accuracy of Nanopore Transcriptome Sequencing for Pediatric Acute Leukemia Lineage Classification in a Resource-Constrained Setting</i>
Authors: Javeria Aijaz, Fouzia Naseer, Shakir Hussain, Muhammad Rafie Raza, Saba Jamal, Shamvil Ashraf, Larissa Furtado, Nickhill Bhakta, Thomas B. Alexander, Jeremy Wang
Journal: Blood (2023)
Favezelimab in Combination with Pembrolizumab in Patients with Heavily Pretreated Anti-PD-1-Refractory Classical Hodgkin Lymphoma: Updated Analysis of an Open-Label Phase 1/2 Study
Authors: John Timmerman, David Lavie, Nathalie A. Johnson, Abraham Avigdor, Peter Borchmann, Charalambos Andreadis, Ali Bazargan, Gareth P. Gregory, Colm Keane, Inna Tzoran, Vladan Vucinic, Pier Luigi Zinzani, Rachel Marceau West, Pallavi Pillai, Patricia Marinello, Alex F. Herrera
Journal: Blood (2023)
Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hematologic Malignancies
Authors: Courtney D. DiNardo, Michael R. Savona, Ashwin Kishtagari, Amir T. Fathi, Kapil N. Bhalla, Samuel Agresta, Sarah Reilly, Caroline Almon, Murphy Hentemann, Denice Hickman, Dillon Corrigan, Meghan Macaraeg, Jessica Piel, Kim Horrigan, Salah Nabhan, Paul Martin, Eytan M. Stein
Journal: Blood (2023)
Loss of Platelet 12-Lipoxygenase Aggravates the Severity of Sars-Cov-2 Infection
Authors: Ana Claudia Andrade, Emile Lacasse, Isabelle Dubuc, Leslie Gudimard, Florian Puhm, Celso Queiroz, Isabelle Allaeys, Julien Prunier, Élizabeth Dumais, Nicolas Flamand, Arnaud Droit, Eric Boilard, Louis Flamand
Journal: Blood (2023)
A Translational Approach to Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman Disease
Authors: Melanie Mumau, Abiola Irvine, Chunyu Ma, Sheila K. Pierson, Brent Shaw, Michael V. Gonzalez, Daniel Korn, Tracey Sikora, Grant Mitchell, David Koslicki, Luke Y. C. Chen, David C. Fajgenbaum
Journal: Blood (2023)
High Efficacy and Excellent Safety Profile of Actalycabtagene Autoleucel, a Humanized CD19 CAR-T Product in r/r B-Cell Malignancies: A Phase II Pivotal Trial
Authors: Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Netra Ghandade, Ruchira Patil, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Rushikesh Patil, Manivasagam S, Neha Sharma, Alok Shetty, Lingaraj Nayak, Bhausaheb Bagal, Shripad Banavali, Gaurav Narula, Preeti Desai, Anisha Navkudkar, Prashant Tembhare, Navin Khattry, Epari Sridhar, Nikhil Patkar, Sumeet Gujral, Tanuja Shet, Uma Sakhadeo, Papagudi Ganesan Subramanian, Jayshree Thorat, Anamika Prashant, Sachin Punatar, Anant Gokarn, Kinjalka Ghosh, Archi Agrawal, Yash Jain, Venkatesh Rangarajan, Shashank Ojha, Shilpushp Bhosle, Siddhartha Laskar, Sangeeta Kakoti, Sumeet Mirgh, Sumathi Hiregoudar, Minal Poojary, Nitin Shetty, Vasundhara Patil, Akshay Baheti, Sanjay Biswas, Gaurav Salunkhe, Kunal Gala, Manju Sengar, Nirali N. Shah, Sattva S. Neelapu, Rahul Purwar
Journal: Blood (2023)
Prothrombotic Profile in Patients with Active Multiple Myeloma and the Impact of Immunomodulators: The Roadmap-MM Study
Authors: Patrick Van Dreden, Loula Papageorgiou, Eleftheria Lefkou, Despina Fotiou, Efstathios Kastritis, Evangelos Terpos, Aurelie Rousseau, Michele Sabbah, Matthieu Grusse, Elisabeth Mbemba, Ismail Elalamy, Meletios Athanasios Dimopoulos, Grigoris Gerotziafas
Journal: Blood (2023)
Outcomes of Patients (pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) and <i>TP53</i> mutation/Loss Treated on the Phase 2 Study of Venetoclax (Ven) Added to Alternating Cladribine (Clad) Plus Low-Dose Cytarabine (LDAC) and Azacitidine (Aza): A Subgroup Analysis
Authors: Jayastu Senapati, Sanam Loghavi, Patrick K Reville, Naval Daver, Gautam Borthakur, Courtney D. DiNardo, Elias Jabbour, Nicholas J. Short, Naveen Pemmaraju, Abhishek Maiti, Ghayas C. Issa, Uday R. Popat, Amin Alousi, Elizabeth J. Shpall, Koji Sasaki, Guillermo Garcia-Manero, Farhad Ravandi, Tapan M. Kadia
Journal: Blood (2023)
ERK1/2 Inhibition Overcomes Resistance to Venetoclax in AML By Inhibiting Drp1 Dependent Mitochondrial Fission
Authors: Priyanka Sharma, Lauren B. Ostermann, Sujan Piya, Baozhen Ke, Natalia Baran, Anudishi Tyagi, Muharrem Muftuoglu, Mahesh Basyal, Qi Zhang, Joanne Munck, Kim-Hien Dao, Martin Sims, Bing Z. Carter, Venkata Lokesh Battula, Michael Andreeff, Gautam Borthakur
Journal: Blood (2023)
Characterization and Quantification of Von Willebrand Factor Proteoforms in Von Willebrand Disease Patients and Healthy Controls: Insights from the Win-Study
Authors: Iris charlotte Kreft, Tirsa T van Duijl, Calvin Van Kwawegen, Winny Phan, Margo Schuller, Carmen van Der Zwaan, Alexander Meijer, Ruben Bierings, Frank W.G. Leebeek, Maartje Van Den Biggelaar
Journal: Blood (2023)
Habit Efficacy Trial: A Multi-Site Randomized Controlled Trial of Community Health Worker Support to Increase Hydroxyurea Adherence of Youth with Sickle Cell Disease
Authors: Nancy S. Green, Deepa Manwani, Banu Aygun, Abena Appiah-Kubi, Kim Smith-Whitley, Haomiao Jia, Arlene Smaldone
Journal: Blood (2023)
1-Year Data Analysis from a Cancer Center Molecular Tumor Board Dedicated to Clonal Hematopoiesis
Authors: Jean-Baptiste Micol, Ahmadreza Arbab, Damien Vasseur, Arnaud Bayle, Mihaela Aldea, Romain Loyaux, Veronique Verge, Veronique Saada, Alice Fievet, Nathalie Auger, Sophie Cotteret, Florence Pasquier, Christophe Willekens, Camille Bigenwald, Cristina Castilla-Llorente, Stephane De Botton, Eric Solary, Elsa Bernard, Etienne Rouleau, Antoine Italiano, Christophe Marzac, Aline Renneville
Journal: Blood (2023)
Dual Split-Signaling TIM3+CLEC12a Targeting CAR T-Cells with Optimized Signaling As a Safe Potential Therapy for Acute Myeloid Leukemia
Authors: Jort J Van Der Schans, Paresh Vishwasrao, Noortje Van Gils, Mashhour Hosny, Ziyu Wang, Jennemiek Van Arkel, Sonja Zweegman, Maria Themeli, Gert Ossenkoppele, Niels W.C.J. van de Donk, Arjan A. Van de Loosdrecht, Linda Smit, Tuna Mutis
Journal: Blood (2023)
Australasian Leukaemia &amp; Lymphoma Group NHL35-Pacific: An Open Label Phase II Study of Pembrolizumab and Chemo-Immunotherapy As First-Line Therapy for Primary Mediastinal B-Cell Lymphoma - Trial in Progress
Authors: Katharine L. Lewis, Piers Blombery, Nagendra Prasad Sungala, Chun Kei Kris Ma, Pratyush Giri, Vinay Vanguru, Tara Cochrane, Joanna Katarzyna Czerwinski, Denise Lee, Nada Hamad, Roslyn Francis, Mannu Walia, Julia Carlson, Belinda E Butcher, Chan Y. Cheah
Journal: Blood (2023)
Impact of Sarcopenia and Subsequent Muscle Loss on Post-CAR T-Cell Outcomes in Relapsed/Refractory Large B-Cell Lymphoma
Authors: Khushali Jhaveri, Ram Thapa, Jerald Noble, Dalia Ercan, Pranit Singh, Johannes Fahrmann, Neeraj Y. Saini, Ranran Wu, Jennifer Dennison, Samir Hanash, Robert R. Jenq, Karnav Modi, Nicholas Figura, Julio C Chavez, Bijal D. Shah, Taiga Nishihori, Aleksandr Lazaryan, Farhad Khimani, Christina A Bachmeier, Kenneth Gage, Asmita Mishra, Fabiana Perna, Marco Davila, Kai Rejeski, Marion Subklewe, Frederick L. Locke, Ciara Louise L. Freeman, Nathan Parker, Michael D. Jain
Journal: Blood (2023)
<i>D</i> <i>DX41</i>-Low Expression Mimics Germline <i>DDX41</i>-Phenotype in Acute Myeloid Leukemia
Authors: Wajma Shahbaz, Vindi Jurinovic, Aarif M. N. Batcha, Christian Rausch, Maja Rothenberg-Thurley, Annika Maria Dufour, Bianka Ksienzyk, Stephanie Schneider, Michaela Neusser, Maria Cristina Sauerland, Dennis Görlich, Wolfgang E. Berdel, Bernhard J. Woermann, Utz Krug, Jan Braess, Wolfgang Hiddemann, Ulrich Mansmann, Sebastian Vosberg, Philipp A. Greif, Karsten Spiekermann, Klaus H Metzeler, Tobias Herold
Journal: Blood (2023)
3-Year Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) As First-Line Therapy in Patients with High-Risk Large B-Cell Lymphoma (LBCL)
Authors: Julio C. Chavez, Michael Dickinson, Javier L. Munoz, Matthew L. Ulrickson, Catherine Thieblemont, Olalekan O. Oluwole, Alex F. Herrera, Chaitra S Ujjani, Yi Lin, Peter A. Riedell, Natasha K. Kekre, Sven de Vos, Christine Lui, Jacob Wulff, Chad M. Williams, Weixin Peng, Ioana Kloos, Hairong Xu, Sattva S. Neelapu
Journal: Blood (2023)
Patients with Down Syndrome and High-Risk B-Acute Lymphoblastic Leukemia Demonstrate Improved Outcomes on a Modified Chemotherapy Regimen: A Report from Children's Oncology Group Study AALL1131
Authors: Vilmarie Rodriguez, Meenakshi Devidas, Zhiguo (Bruce) Chen, Andrew J Carroll, Nyla A. Heerema, Michael J. Borowitz, Brent L. Wood, William L. Carroll, Naomi J Winick, Elizabeth A. Raetz, Mignon L. Loh, Michael J. Burke, Wanda L. Salzer, Stephen P. Hunger, Karen R. Rabin
Journal: Blood (2023)
Interactions between Integrin α9β1 and VCAM-1 Promote Neutrophil Hyperactivation and Deep Vein Thrombosis in a Murine Model of Lung Cancer
Authors: Nilesh Pandey, Harpreet Kaur, Shiva Jashwanth Gaddam, Tarek Magdy Mohamed, Karen Stokes, Kavitha Beedupalli, Nirav Dhanesha
Journal: Blood (2023)
Intra-Leukemic IFNγ Signaling Mediates Cell Cycle Suppression and Chemoresistance in AML
Authors: Daiki Karigane, Amy C Fan, Kensuke Kayamori, Yusuke Nakauchi, Thomas Koehnke, Athreya S Rangavajhula, Asiri Ediriwickrema, Ravindra Majeti
Journal: Blood (2023)
Blood-Brain Barrier and Neuronal Damage during Icans in Patients Treated with Anti-CD19 CAR-T Cells
Authors: Eugenio Galli, Anna Modoni, Luca Battistini, Monica Rossi, Gisella Guerrera, Ilaria Pansini, Stefan Hohaus, Andrea Bacigalupo, Simona Sica, Patrizia Chiusolo, Ferderica Sorà
Journal: Blood (2023)
Adoptive Transfer of T Cells Genetically Engineered to Express T-Cell Receptors Targeting Neoantigens Arising from p53 and Ras Hotspot Mutations in Hematologic Malignancies
Authors: Kathryn M Cappell, Sanghyun P Kim, Noam Levin, Norris Lam, Christina Amatya, Lauren C Cutmore, Rachel Beyer, Steven A Rosenberg, James N Kochenderfer
Journal: Blood (2023)
<i>CNS Irradiation in Adult De Novo B-Precursor ALL / Lbl: Results of the Randomized GMALL T</i> <i>rial 08/2013 Indicate Potential Antileukemic Efficacy</i>
Authors: Nicola Goekbuget, Björn Steffen, Kathrin Nachtkamp, Boris Böll, Veit L. Buecklein, Christoph Faul, Jens Panse, Christoph Röllig, Folker Schneller, Bernd Spriewald, Matthias Stelljes, Max S. Topp, Andreas Viardot, Vladan Vucinic, Knut Wendelin, Monika Brüggemann, Monika Szczepanowski, Stefan Schwartz, Thomas Burmeister, Axel Benner, Nicholas Schreck, Lena Reiser, Hubert Serve, Walter Fiedler
Journal: Blood (2023)
Accelerating Immune Reconstitution in HSCT Patients through iPSC-Derived Thymic Epithelial Cells
Authors: Abdulvasey Mohammed, Hanh Dan Nguyen, Kelsea Hubka, Wenqing Wang, Priscila Slepicka, Phd, Ben Solomon, Martin Arreola, Zihao Zheng, Andrew Gentles, Katja G. Weinacht
Journal: Blood (2023)
Mitochondrial Damage-Associated Molecular Patterns (DAMPs) Contribute to the Development of Murine Antibody-Mediated Transfusion-Related Acute Lung Injury (TRALI)
Authors: Genevieve Marcoux, Johan Rebetz, Ellen Moore, Hilma Cederholm, David McGauran, Karl Johansson, John W Semple
Journal: Blood (2023)
Circadian Rhythms Metabolically Regulate Bone Marrow Retained Primitive Hematopoietic Stem Cell Size and Function
Authors: Priyasmita Chakrabarti, Nicola K. Wilson, Abhishek K. Singh, Iwo Kucinski, Lizeth-Alejandra Ordonez-Moreno, Sony Sharma, Sarah J. Kinston, Montaser B. Haddad, Orit Kollet, Ekaterina Petrovich-Kopitman, Avik Choudhuri, Leonard I. Zon, Jose A. Cancelas, John E. Dick, Stephanie Xie, Bertie Göttgens, Tsvee Lapidot
Journal: Blood (2023)
Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Correlative Analysis
Authors: Christina Poh, Victor A Chow, Ryan C Lynch, Chaitra S Ujjani, Mazyar Shadman, Brian G Till, Vikram Raghunathan, Edus H Warren, Jordan Gauthier, Stephen D Smith, Taran Gujral, Chihiro Morishima, Qian Wu, Jenna M Voutsinas, Amy Sperling, Joshua Dizon, David G Maloney, Ajay K Gopal
Journal: Blood (2023)
DNMT3A R882H Exhibits Greater Inflammatory Potential Than R882C in Primary Hematopoietic Stem and Progenitor Cell Knock-in Model and Population Data
Authors: Alexander J Silver, Donovan J Brown, Caitlyn Vlasschaert, Pawan Bhat, Fabio Puddu, Joseph C Van Amburg, Matthew T Villaume, Melissa A Fischer, Maria P Arrate, Yu Wang, Jamie Scotcher, Kristy Stengel, Brianna Nicole Smith, Brian Sharber, Chad R Potts, Mark Consugar, Jonathan Brett Heimlich, Yaomin Xu, P. Brent Ferrell, Alexander G. Bick, Michael R. Savona
Journal: Blood (2023)
Patients with Relapsed Large B-Cell Lymphoma after 12 Months Have a Similarly Poor Prognosis As Patients with a Relapse before 12 Months
Authors: Hilde T Van Der Galien, Hilde AM Kooistra, Robby Kibbelaar, Nic JGM Veeger, Marcel Nijland, Geert A. Huls, Tom Van Meerten, Rozemarijn S Van Rijn
Journal: Blood (2023)
Characterization of JNJ-79635322, a Novel BCMAxGPRC5DxCD3 T-Cell Redirecting Trispecific Antibody, for the Treatment of Multiple Myeloma
Authors: Ram Pillarisetti, Danlin Yang, Jianhong Yao, Melissa Smith, Leopoldo Luistro, Peter Vulfson, James Testa, Kathryn Packman, Scott Brodeur, Ricardo M. Attar, Yusri Elsayed, Ulrike Philippar
Journal: Blood (2023)
A Phase II Study of Loncastuximab Tesirine As Consolidation Strategy in Patients with LBCL in PR at Day 30 after CAR T-Cell Therapy
Authors: Ajlan Al Zaki, Lei Feng, Jason Westin, Ranjit Nair, Luis Fayad, Grace Watson, Sherry Adkins, Elizabeth J. Shpall, Mario L. Marques-Piubelli, Jared Henderson, Loretta J. Nastoupil, Christopher R. Flowers, Sairah Ahmed, Sattva S. Neelapu, Paolo Strati
Journal: Blood (2023)
French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): Update of the IFM Study from the Descar-T Registry
Authors: Sarah Cayla, Benoit Ferment, Noemie Bigot, Denis Caillot, Ingrid Lafon, Lionel Karlin, Anne Lazareth, Cyrille Touzeau, Xavier Leleu, Niels Moya, Stephanie Harel, Aurore Perrot, Pierre Bories, Laure Vincent, Sylvain Lamure, Mohamad Mohty, Florent Malard, Salomon Manier, Ibrahim Yakoub-Agha, Anne-Marie Stoppa, Gabriel Brisou, Olivier Decaux, Roch Houot, Steven Le Gouill, Jerome Lambert, Thierry Facon, Herve Avet Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood (2023)
Trial in Progress: A Phase I/II Study of Tafasitamab Plus Lenalidomide in Patients with Relapsed CNS Lymphoma
Authors: Michael P Randall, Andreas Rauschecker, Liam Gima-Lange, Jenai Wilmoth, Lingjing Chen, Ming Lu, Huimin Geng, Haifaa Abdulhaq, James L. Rubenstein
Journal: Blood (2023)
A Phase 1 Study of PIT565, a First-in-Class, Anti-CD3, Anti-CD19, Anti-CD2 Trispecific Antibody in Patients with Relapsed and/or Refractory B-Cell Malignancies
Authors: Irit Avivi Mazza, Pere Barba, Junichiro Yuda, Maria Lia Palomba, Juan Pablo Alderuccio, Ciel De Vriendt, Paolo Corradini, Francesca Lorraine Wei Inng Lim, Pier Luigi Zinzani, Nitin Jain, Jessica T. Leonard, Michelle Coulson, Nadia Hassounah, Xiaoling Yang, Haihui Lu, Andrew Lewandowski, Joseph Ryan Polli, Matthieu Klopfenstein, Alessandro Pastore, Gabriel Brisou
Journal: Blood (2023)
Sequential Imaging with Diffusion-Weighted Whole-Body MRI (DW-MRI) and PET-CT Identifies Patients at High Risk of Relapse in Multiple Myeloma
Authors: Carolina Schinke, Leo Rasche, Cody Ashby, Rudy van Hemert, Sharmilan Thanendrarajan, Samer Al Hadidi, Maurizio Zangari, Clyde Bailey, Daisy V. Alapat, John D Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Frits van Rhee, Niels Weinhold
Journal: Blood (2023)